000			01918 a2200553 4500
005			20250517144141.0
264		0	_c20170424
008			201704s 0 0 eng d
022			_a1096-0333
024	7		_a10.1016/j.taap.2017.03.016 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuang, Hai
245	0	0	_aBaicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs. _h[electronic resource]
260			_bToxicology and applied pharmacology _c05 2017
300			_a36-43 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnimals, Newborn
650	0	4	_aAntiviral Agents _xpharmacology
650	0	4	_aBiomarkers _xblood
650	0	4	_aDNA, Viral _xgenetics
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Resistance, Viral
650	0	4	_aDrug Therapy, Combination
650	0	4	_aDucks
650	0	4	_aFlavonoids _xpharmacology
650	0	4	_aGuanine _xanalogs & derivatives
650	0	4	_aHep G2 Cells
650	0	4	_aHepatitis B Surface Antigens _xblood
650	0	4	_aHepatitis B e Antigens _xblood
650	0	4	_aHepatitis B virus _xdrug effects
650	0	4	_aHepatitis B, Chronic _xdiagnosis
650	0	4	_aHepatocyte Nuclear Factor 1-alpha _xgenetics
650	0	4	_aHepatocyte Nuclear Factor 4 _xgenetics
650	0	4	_aHost-Pathogen Interactions
650	0	4	_aHumans
650	0	4	_aRNA, Viral _xbiosynthesis
650	0	4	_aTime Factors
650	0	4	_aTranscription, Genetic _xdrug effects
650	0	4	_aTransfection
650	0	4	_aViral Load
700	1		_aZhou, Wei
700	1		_aZhu, Haiyan
700	1		_aZhou, Pei
700	1		_aShi, Xunlong
773	0		_tToxicology and applied pharmacology _gvol. 323 _gp. 36-43
856	4	0	_uhttps://doi.org/10.1016/j.taap.2017.03.016 _zAvailable from publisher's website
999			_c26996862 _d26996862